GS25-B001

N/A

Report date: 2025/10/21 17:53:12
NME

Base Information

Drug NameGS25-B001
Drug Alias NameGS25-B001
ClassificationOther
Mechanisms of ActionInterleukin-13 modulators
TargetsInterleukin-13
Therapy Area/IndicationsDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A